The New England Journal of Medicine 2005 Jerry Avorn - Abstracts
| The New England Journal of Medicine 2005 Jerry Avorn | |||||
| Title | Subject | Authors | |||
|---|---|---|---|---|---|
| FDA standards - good enough for government work? | Health | Jerry Avorn | |||
| Risk of death in elderly users of conventional vs. atypical antipsychotic medications. | Health | Philip S. Wang, Daniel H. Solomon, Helen Mogun, Jerry Avorn, Michael A. Fischer, Sebastian Schneeweiss, M. Alan Brookhart | |||
| Torcetrapib and Atorvastatin-Should marketing drive the research agenda? | Health | Jerry Avorn | |||
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.